RecruitingNCT05234567

A Prospective Sub-Study of the Global Hypophosphatasia Registry

Studying Hypophosphatasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Alexion Pharmaceuticals, Inc.
Intervention
Asfotase Alfa(biological)
Enrollment
30 target
Eligibility
All sexes
Timeline
2022 – 2028

Study locations (12)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05234567 on ClinicalTrials.gov

Other trials for Hypophosphatasia

Additional recruiting or active studies for the same condition.

See all trials for Hypophosphatasia →

← Back to all trials